Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Delimobil has multiplied the revenue from carsharing for business

12/19/24 DELI

En+ Group suspends giant wind farm project in Blagoveshchensk

12/19/24 ENPG

Shareholders of Ozon Pharmaceuticals approved dividends

12/18/24 OZPH

Alrosa's production volume by the end of the year will amount to 33 mln carats

12/18/24 ALRS

Gazprom shipped LNG to Italy for the first time from the Portovaya terminal

12/18/24 GAZP

Samolet will conduct a bond buyback

12/18/24 SMLT

Ozone Pharmaceuticals has started clinical trials of a biotech drug

12/18/24 OZPH

Fesco opened a subsidiary in Vietnam

12/18/24 FESH

Novoship's Board of Directors recommends dividends

12/18/24 NOMP

T-Bank and Rosbank's RAS profit for 11 months increased by 60%

12/18/24 T